University Hospital Galway is a major acute hospital in Galway, Ireland. It is managed by Saolta University Health Care Group.

There are 521 beds in University Hospital Galway.

During the past decade, University Hospital Galway conducted 95 clinical trials. In the 10-year time frame, 95 clinical trials started and 35 clinical trials were completed, i.e. on average, 36.8% percent of trials that started reached the finish line to date. In the past 5 years, 32 clinical trials started and 24 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital Galway" #1 sponsor was "Cancer Trials Ireland" with 34 trials, followed by "National University of Ireland, Galway, Ireland" with 11 trials sponsored, "University College Hospital Galway" with 11 trials sponsored, "National Cancer Institute (NCI)" with 7 trials sponsored and "Boston Scientific Corporation" with 7 trials sponsored. Other sponsors include 102 different institutions and companies that sponsored additional 75 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Galway" #1 collaborator was "Cancer Trials Ireland" with 5 trials as a collaborator, "University College Hospital Galway" with 5 trials as a collaborator, "Merck Sharp & Dohme LLC" with 4 trials as a collaborator, "Breast International Group" with 3 trials as a collaborator and "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials as a collaborator. Other collaborators include 120 different institutions and companies that were collaborators in the rest 106 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital Galway" are "Breast Cancer" (13 trials), "Coronary Artery Disease" (10 trials), "Multiple Myeloma" (8 trials), "Crohn's Disease" (6 trials) and "Lung Cancer" (6 trials). Many other conditions were trialed in "University Hospital Galway" in a lesser frequency.

Most popular intervention types in "University Hospital Galway" are "Drug" (89 trials), "Device" (33 trials), "Other" (33 trials), "Procedure" (16 trials) and "Biological" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Dexamethasone" (6 trials), "Bortezomib" (5 trials), "Cyclophosphamide" (5 trials) and "Docetaxel" (5 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital Galway" are 135 trials for "All" genders, 30 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are 59 active trials in "University Hospital Galway". 1 are not yet recruiting, 18 are recruiting, 39 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 90 completed trials in University Hospital Galway, 2 suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital Galway, 8 "Phase 1" clinical trials were conducted, 41 "Phase 2" clinical trials and 57 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 42 trials that are defined as “Not Applicable".